American Capital Advisory’s GSK GSK Stock Holding History

American Capital Advisory’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.19K	Buy	94 +68	+262%	+$3.69K	﹤0.01%	396
2025 Q4	$1.28K	Hold	26	–	–	﹤0.01%	542
2025 Q3	$1.12K	Buy	+26	New	+$1.02K	﹤0.01%	522

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

American Capital Advisory's GSK Position: Q1 2026 in Review

American Capital Advisory increased its GSK (GSK) stake by 262% in Q1 2026, buying an estimated $3.69K and bringing the position to 94 shares worth $5.19K. The position accounts for ﹤0.01% of the portfolio, ranked #396.

American Capital Advisory first reported a position in GSK in Q3 2025 and has held it in 3 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

American Capital Advisory held 94 shares of GSK worth $5.19K as of Q1 2026.
American Capital Advisory bought 68 GSK shares in Q1 2026, an estimated $3.69K.
GSK made up ﹤0.01% of American Capital Advisory's portfolio in Q1 2026, its #396 holding.
American Capital Advisory first reported a position in GSK in Q3 2025 and has held it in 3 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on American Capital Advisory's 13F filing for Q1 2026, filed 29 Apr 2026.